Common Shares and Warrants (Detail Narrative) - USD ($) |
1 Months Ended | 3 Months Ended | 6 Months Ended | ||||
---|---|---|---|---|---|---|---|
Oct. 03, 2023 |
Feb. 16, 2024 |
Oct. 26, 2023 |
Nov. 30, 2023 |
Nov. 30, 2022 |
Feb. 29, 2024 |
Feb. 28, 2023 |
|
Stock issued during period, shares | $ 1,119,250 | ||||||
Proced from issuance of common stock | 1,063,475 | ||||||
Transferred to trust account | $ 32,110 | ||||||
Term | 3 years 7 months 17 days | ||||||
Stock based compensation | $ 53,953 | $ 68,776 | $ 53,953 | $ 79,302 | |||
Unrecognized non-cash compensation costs | $ 39,117 | ||||||
Non-vested stock options | 11,750 | ||||||
Option strike price | $ 3.27 | ||||||
Weighted Average Remaining Contractual Life | 26 days | ||||||
Exercise price | $ 0.95 | ||||||
Officers And Employees [Member] | |||||||
Granted options | 85,000 | ||||||
Exercise price, option | $ 1.15 | ||||||
Term | 5 years | ||||||
Officers And Employees Additional [Member] | |||||||
Granted options | 85,000 | ||||||
Exercise price, option | $ 1.15 | ||||||
Term | 5 years | ||||||
Securities Purchase Agreement [Member] | |||||||
Proced from issuance of common stock | $ 73 | $ 1,063,475 | |||||
Purchase of common stock | 889,272 | ||||||
Purchase of Pre-funded warrants | 729,058 | 113,702 | |||||
Common shares to be purchase | 1,618,330 | 1,444,741 | 1,558,443 | ||||
Offering price | $ 0.97 | $ 2.31 | |||||
Exercise price | $ 0.97 | $ 2.185 | |||||
Net proceeds | $ 1,250,000 | ||||||
Equity Incentive Plan [Member] | |||||||
Description of incentives plan | The Company has established an Equity Incentive Plan which was most recently amended by the Company’s shareholders on May 9, 2023. Pursuant to the amendments which were effected on January 18, 2024 when the Company filed a Form S-8 Registration Statement, the Equity Incentive Plan now has an evergreen formula, whereby on January 1 each year commencing January 1, 2024, the number of shares issuable pursuant to the Equity Incentive Plan may be increased to a number equal to up to 10% of the issued share capital on December 31 of the previous year. | ||||||
Aggregate common shares issuable | 1,037,544 | ||||||
Additional shares to be issued | 527,111 | ||||||
Placement Agent [Member] | |||||||
Proced to direct offering | $ 3,000,000.0 | ||||||
Common shares to be purchase | 54,546 | ||||||
Exercise price | $ 2.8875 |
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- Definition The number of shares converted in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Exercise or strike price stated in the contract for options indexed to the issuer's equity shares. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition The cash inflow from the additional capital contribution to the entity. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition The cash inflow associated with the amount received from entity's raising of capital via private rather than public placement. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Amount of noncash expense for share-based payment arrangement. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Description of terms of share-based payment arrangement. Includes, but is not limited to, type of award or grantee and reason for issuance. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Net number of share options (or share units) granted during the period. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
X | ||||||||||
- Definition Weighted average remaining contractual term of outstanding stock options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Number of shares that have been repurchased during the period and have not been retired and are not held in treasury. Some state laws may govern the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|